Dr. Jahagirdar is a member of the Experimental Therapeutics Committee of the Alliance for Clinical Trials in Oncology to help design and conduct clinical trials of new cancer treatments throughout the United States, along with his colleagues from Memorial Sloan Kettering Cancer Center, Harvard's Dana-Farber Cancer Institute, Mayo Clinic and other institutions. He has co-written a book chapter in the Textbook of Malignant Hematology, and his research is published in such journals as Nature, Journal of Clinical Investigation, Blood, Experimental Hematology and Leukemia. Dr. Jahagirdar is president-elect of the Minnesota Society of Clinical Oncology. In addition, he has received several awards and honors, including the Clinical Excellence Award of University of Minnesota-Regions Hospital, Outstanding Clinical Mentor Awards for training of oncologists-hematologists, the National Cancer Institute's MMCCOP-Silver Certificate for contribution to clinical trials in oncology, Alpha-Omega-Alpha Honor Society, University of Minnesota Department of Medicine Fellow Research Award, and the Blood and Marrow Transplant Award.

hematologic malignancies and solid tumors and has a special interest in early (novel) therapeutics and Phase 1 research.